Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking

被引:30
作者
Ensenat-Waser, Roberto
Nestor Vicente-Salar, Alfredo Santana
Cigudosa, Juan C.
Roche, Enrique
Soria, Bernat
Reig, Juan A. [1 ]
机构
[1] Univ Miguel Hernandez, Inst Bioingn, Unidad Bioquim & Terapia Celular, Alicante 03550, Spain
[2] Ctr Nacl Invest Oncol, Madrid, Spain
关键词
cell differentiation; cell culture; tumorigenicity; flow cytometry; Oct4; karyotype;
D O I
10.1290/0509063.1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The differentiation of mouse embryonic stem (ES) cells can lie induced in vitro after leukemia inhibitory factor (LIF) withdrawal and further enhanced by the formation of "embryoid body" (EB) aggregates. This strategy is being used in order to optimize differentiation protocols that would result in functional cells for experimental cell replacement therapies. However, this study presents the possibility for residual undifferentiated cells to survive after standard in vitro procedures. Mouse ES cells were stably transfected with the enhanced green fluorescent protein (EGFP), under the control of the Oct4 promoter, a transcription factor that is expressed in undifferentiated ES cells but clown-regulated on differentiation. Residual fluorescent cells were isolated from EBs that were cultured in standard conditions in absence of LIF. These residual cells displayed recurrent gain of chromosomes 8 and 9. Residual fluorescent cells, further expanded in absence of LIF and cultured as EBs, still displayed a significant Oct4 expression in comparison with parental transfected ES cells. Consequently, these residual cells have an intrinsic resistance to differentiate. The behavior of these cells, observed in vitro, can be overcome in vivo, as they were able to induce teratomas in subcutaneously injected nude mice. Residual undifferentiated cells displayed slight levels of VASA and DAZL expression. These results demonstrate that mouse ES cells cultured in vitro, in standard conditions, can spontaneously acquire recurrent karyotypical changes that may promote an undifferentiated stage, being selected in standard culture conditions in vitro.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 32 条
[1]   Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells [J].
Blyszczuk, P ;
Czyz, J ;
Kania, G ;
Wagner, M ;
Roll, U ;
St-Onge, L ;
Wobus, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :998-1003
[2]   Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines [J].
Buehr, M ;
Nichols, J ;
Stenhouse, F ;
Mountford, P ;
Greenhalgh, CJ ;
Kantachuvesiri, S ;
Brooker, G ;
Mullins, J ;
Smith, AG .
BIOLOGY OF REPRODUCTION, 2003, 68 (01) :222-229
[3]   Nanog:: A new recruit to the embryonic stem cell orchestra [J].
Cavaleri, F ;
Schöler, HR .
CELL, 2003, 113 (05) :551-552
[4]  
DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
[5]   Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells [J].
Draper, JS ;
Smith, K ;
Gokhale, P ;
Moore, HD ;
Maltby, E ;
Johnson, J ;
Meisner, L ;
Zwaka, TP ;
Thomson, JA ;
Andrews, PW .
NATURE BIOTECHNOLOGY, 2004, 22 (01) :53-54
[6]  
GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141
[7]   Derivation of embryonic germ cells and male gametes from embryonic stem cells [J].
Geijsen, N ;
Horoschak, M ;
Kim, K ;
Gribnau, J ;
Eggan, K ;
Daley, GQ .
NATURE, 2004, 427 (6970) :148-154
[8]  
Höpfl G, 2004, METH MOL B, V254, P79
[9]   Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease [J].
Kim, JH ;
Auerbach, JM ;
Rodríguez-Gómez, JA ;
Velasco, I ;
Gavin, D ;
Lumelsky, N ;
Lee, SH ;
Nguyen, J ;
Sánchez-Pernaute, R ;
Bankiewicz, K ;
McKay, R .
NATURE, 2002, 418 (6893) :50-56
[10]   Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts [J].
Klug, MG ;
Soonpaa, MH ;
Koh, GY ;
Field, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :216-224